SCHEMBL13523217

SCHEMBL13523217

Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c12

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 19/20 0.80
KIT P10721 11/20 0.80
FLT3 P36888 11/20 0.80
CSF1R P07333 7/20 0.80
FLT1 P17948 7/20 0.80
FLT4 P35916 6/20 0.80
FYN P06241 5/20 0.80
LYN P07948 5/20 0.80
BLK P51451 5/20 0.80
SRC P12931 4/20 0.80
LCK P06239 4/20 0.80
ABL1 P00519 3/20 0.80
NTRK1 P04629 4/20 0.61
EPHA2 P29317 3/20 0.58
NTRK2 Q16620 3/20 0.58
MARK2 Q7KZI7 3/20 0.58
AURKB Q96GD4 3/20 0.58
RPS6KA5 O75582 2/20 0.58
RPS6KB1 P23443 2/20 0.58
AXL P30530 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL421748 0.89 KDR (1.00) KDRKITFLT3CSF1RFLT1
SCHEMBL13523211 0.87 KDR (0.80) KDRKITFLT3CSF1RFLT1
SCHEMBL422687 0.80 KDR (0.79) KDRKITFLT3CSF1RFLT1
SCHEMBL420194 0.80 KDR (0.80) KDRKITFLT3CSF1RFLT1
SCHEMBL421150 0.78 KDR (0.79) KDRKITFLT3CSF1RFLT1
SCHEMBL425258 0.77 KDR (0.82) KDRKITFLT3CSF1RFLT1
SCHEMBL424599 0.77 KDR (0.84) KDRKITFLT3CSF1RFLT1
SCHEMBL424715 0.77 KDR (1.00) KDRKITFLT3CSF1RFLT1
SCHEMBL13523213 0.77 KDR (0.81) KDRKITFLT3CSF1RFLT1
SCHEMBL422629 0.77 KDR (0.75) KDRKITFLT3CSF1RFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004306-A1 PIGF-1 Assay and kits and components thereof ABBOTT LABORATORIES (US) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004306-A1 PIGF-1 Assay and kits and components thereof PGF, FLT1, HDGF KDR 9/4885KIT 140/4885FLT3 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.